Filana Therapeutics (FLNA) Change in Cash (2010 - 2026)
Filana Therapeutics (FLNA) posted quarterly Change in Cash of -$3.9 million for Q2 2026, up 21.33% year-over-year from -$3.2 million in Q2 2025, and up 56.41% quarter-over-quarter from -$8.9 million in Q1 2026.
Filana Therapeutics (FLNA) Change in Cash (2010 - 2026) Analysis & Trends
Filana Therapeutics' Change in Cash history runs 17 years deep, the most recent figure standing at -$3.9 million for Q2 2026.
- In Q2 2026, Change in Cash rose 21.33% year-over-year to -$3.9 million; the TTM figure through Jun 2026 stood at -$29.7 million (up 68.71% YoY), while the FY2025 annual figure was -$33.1 million, down 544.64% from the prior year.
- Change in Cash for Q2 2026 stood at -$3.9 million, up from -$8.9 million in the prior quarter.
- The five-year high for Change in Cash was $83.1 million in Q2 2024, with the low at -$60.4 million in Q4 2024.
- The 5-year median for Change in Cash is -$11.9 million (2022), against an average of -$8.4 million.
- The sharpest annual moves came in 2024 and 2025: Change in Cash soared 536.82% in 2024, then plunged 470.79% in 2025.
- Filana Therapeutics' Change in Cash stood at $26.4 million in 2022, then sank by 180.5% to -$21.2 million in 2023, then plunged by 184.74% to -$60.4 million in 2024, then surged by 82.49% to -$10.6 million in 2025, then surged by 63.21% to -$3.9 million in 2026.
- Business Quant data shows FLNA's Change in Cash at -$3.9 million in Q2 2026, -$8.9 million in Q1 2026, and -$10.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - | -3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.89 Mn |
| Mar 31, 2026 | -8.93 Mn |
| Dec 31, 2025 | -10.58 Mn |
| Sep 30, 2025 | -6.30 Mn |
| Jun 30, 2025 | -4.95 Mn |
| Mar 31, 2025 | -11.25 Mn |
| Dec 31, 2024 | -60.40 Mn |
| Sep 30, 2024 | -18.31 Mn |
| Jun 30, 2024 | 83.12 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | -21.21 Mn |
| Sep 30, 2023 | -26.09 Mn |
| Jun 30, 2023 | -19.03 Mn |
| Mar 31, 2023 | -13.55 Mn |
| Dec 31, 2022 | 26.35 Mn |
| Sep 30, 2022 | -22.57 Mn |
| Jun 30, 2022 | -12.46 Mn |
| Mar 31, 2022 | -23.74 Mn |
| Dec 31, 2021 | -8.09 Mn |
| Sep 30, 2021 | -36.73 Mn |